Projects per year
Fingerprint Dive into the research topics where Matthew Philip Goetz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 20 Similar Profiles
Breast Neoplasms
Medicine & Life Sciences
Tamoxifen
Medicine & Life Sciences
Cytochrome P-450 CYP2D6
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
oxaliplatin
Medicine & Life Sciences
irinotecan
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Hormonal Antineoplastic Agents
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2005 2021
P-1: The Role of CHFR in Tumorigenesis and Paclitaxwl-Sensitivity in Breast Cance
Gendler, S. J., Vachon, C. M., Suman, V. J., Ingle, J. N., Lingle, W. L., Couch, F. J., Goetz, M. P., Haluska, P. R. J., Chen, J., Hawse, J. R., Wang, L. M., Visscher, D. W., Galanis, E., Ingle, J. N. & Ingle, J. N.
7/1/05 → 8/31/21
Project: Research project
Breast Neoplasms
Research Personnel
Research
Biostatistics
Translational Medical Research
Pharmacogenetics
Tamoxifen
Biotransformation
Cytochrome P-450 CYP2D6
Breast Neoplasms
Research Output 2002 2019
Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2
Dudenkov, T. M., Liu, D., Cairns, J., Devarajan, S., Zhuang, Y., Ingle, J. N., Buzdar, A. U., Robson, M. E., Kubo, M., Batzler, A., Barman, P., Jenkins, G. D., Carlson, E. E., Goetz, M. P., Northfelt, D. W., Moreno Aspitia, A., Desta, Z., Reid, J. M., Kalari, K. R., Wang, L. M. & 1 others, , Jan 1 2019, In : Clinical pharmacology and therapeutics.Research output: Contribution to journal › Article
Open Access
Aromatase Inhibitors
Genome-Wide Association Study
Single Nucleotide Polymorphism
Pharmaceutical Preparations
Breast Neoplasms
2
Citations
(Scopus)
Breast cancer, version 3.2018 featured updates to the NCCN guidelines
Goetz, M. P., Gradishar, W. J., Anderson, B. O., Abraham, J., Aft, R., Allison, K. H., Blair, S. L., Burstein, H. J., Dang, C., Elias, A. D., Farrar, W. B., Giordano, S. H., Goldstein, L. J., Isakoff, S. J., Lyons, J., Kelly Marcom, P., Mayer, I. A., Moran, M. S., Mortimer, J., O’Regan, R. M. & 13 others, , Feb 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 2, p. 118-126 9 p.Research output: Contribution to journal › Article
Open Access
Adjuvant Chemotherapy
Hormones
Guidelines
Breast Neoplasms
Therapeutics
Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy
Al-Hilli, Z., Choong, G., Keeney, M. G., Visscher, D. W., Ingle, J. N., Goetz, M. P. & Jakub, J. W., Aug 15 2019, In : Breast Cancer Research and Treatment. 176, 3, p. 709-716 8 p.Research output: Contribution to journal › Article
Neoadjuvant Therapy
Breast Neoplasms
Drug Therapy
Cyclophosphamide
Anthracyclines
Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM
Goetz, M. P., Suman, V. J., Nakamura, Y., Kiyotani, K., Jordan, V. C. & Ingle, J. N., Aug 1 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 22, p. 1982-1983 2 p.Research output: Contribution to journal › Article
Tamoxifen
Breast Neoplasms
Recurrence
The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1
Cairns, J., Ingle, J. N., Kalari, K. R., Shepherd, L. E., Kubo, M., Goetz, M. P., Weinshilboum, R. M. & Wang, L. M., Apr 3 2019, In : Breast Cancer Research. 21, 1, 47.Research output: Contribution to journal › Article
Open Access
Early Growth Response Protein 1
Lemur
Long Noncoding RNA
Aromatase Inhibitors
Protein-Tyrosine Kinases